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itochondrial genetic and metabolic stress causes
activation of calcineurin (Cn), NFAT, ATF2, and
NF
 
 
 
B/Rel factors, which collectively alter the ex-
pression of an array of nuclear genes. We demonstrate here
that mitochondrial stress–induced activation of NF
 
 
 
B/Rel
factors involves inactivation of I
 
 
 
B
 
 
 
 through Cn-mediated
dephosphorylation. Phosphorylated I
 
 
 
B
 
 
 
 is a substrate for
Cn phosphatase, which was inhibited by FK506 and RII
peptide. Chemical cross-linking and coimmunoprecipitation
show that NF
 
 
 
B/Rel factor–bound I
 
 
 
B
 
 
 
 forms a ternary
complex with Cn under in vitro and in vivo conditions that
was sensitive to FK506. Results show that phosphorylation
M
 
at S313 and S315 from the COOH-terminal PEST domain
of I
 
 
 
B
 
 
 
 is critical for binding to Cn. Mutations at S313/
S315 of I
 
 
 
B
 
 
 
 abolished Cn binding, inhibited Cn-mediated
increase of Rel proteins in the nucleus, and had a dominant-
negative effect on the mitochondrial stress–induced expres-
sion of RyR1 and cathepsin L genes. Our results show the
distinctive nature of mitochondrial stress–induced NF
 
 
 
B/Rel
activation, which is independent of IKK
 
 
 
 and IKK
 
 
 
 kinases
and affects gene target(s) that are different from cytokine
and TNF
 
 
 
-induced stress signaling. The results provide new
 
insights into the role of Cn as a critical link between Ca
 
2
 
 
 
signaling and NF
 
 
 
B/Rel activation.
 
Introduction
 
NF
 
 
 
B/Rel family transcription factors are activated under
various stress conditions and play critical roles in diverse cellular
processes such as growth, development, immune response,
inflammation, apoptosis, and oncogenesis (Beg and Baldwin,
1993; Grilli et al., 1993; Pahl, 1999). The active factors con-
sist of homo- or heterodimers of Rel family proteins (RelA,
RelB, c-Rel, p50, and p52), which bind to DNA in a se-
quence-specific manner through conserved Rel DNA-bind-
ing domain and mediate transcription activation or repression
of target genes (Beg and Baldwin, 1993; Israel, 1995; Pahl,
1999). I
 
 
 
B
 
 
 
 and I
 
 
 
B
 
 
 
 are the two major cytoplasmic inhib-
itory proteins, along with other less characterized factors includ-
 
ing I
 
 
 
B
 
 
 
, I
 
 
 
B
 
 
 
, and Bcl-3, which bind to Rel proteins and re-
strict their nuclear entry.
Major differences between I
 
 
 
B
 
 
 
 and I
 
 
 
B
 
 
 
 factors have
been reported in terms of tissue/cell distribution, rates of
synthesis/degradation, response to different stimuli both at
transcription and posttranslation levels, mechanisms by
which they sequester Rel factors in the cytoplasm, and finally,
their nuclear entry and exit (Chu et al., 1996; Johnson et al.,
1999). Some studies show that I
 
 
 
B
 
 
 
 plays a more important
role in the constitutive phase of NF
 
 
 
B/Rel function,
whereas I
 
 
 
B
 
 
 
 regulates the stress-induced activation of the
factors (Tam and Sen, 2001). IKK-dependent phosphorylation
at the NH
 
2
 
-terminal sites (Ser32 and -36 in the case of I
 
 
 
B
 
 
 
and S19 and -23 in the case of I
 
 
 
B
 
 
 
) is an important regulatory
step for ubiquitin-dependent degradation of these inhibitory
factors and activation of NF
 
 
 
B/Rel (Ghosh and Karin,
2002). Recently, Fenwick et al. (2000) also showed that
members of 
 
 
 
B-Ras G proteins bind to I
 
 
 
B
 
 
 
 and regulate
the rate of its degradation. Phosphorylation at the COOH-
terminal acidic PEST domain has also been shown to be
important for the function of I
 
 
 
B
 
 
 
 (Chu et al., 1996;
McKinsey et al., 1997; Tran et al., 1997), though unphos-
phorylated inhibitory protein seems to bind to Rel proteins
with equal efficiency (Thompson et al., 1995; Chu et al.,
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1996; Weil et al., 1997). However, the precise mechanisms
of inactivation of I
 
 
 
B
 
 
 
 and the release of NF
 
 
 
B/Rel dimeric
proteins remain unclear.
The possible regulation of the NF
 
 
 
B/Rel pathway by
Ca
 
2
 
 
 
 signaling was indirectly implied in studies showing
that transcription activation of IL-2, an NF
 
 
 
B target gene,
was adversely affected by known inhibitors of calcineurin
(Frantz et al., 1994; Chu et al., 1996). However, the details
of this pathway remain unclear. The Ca
 
2
 
 
 
 and calmodulin-
dependent phosphatase calcineurin (Cn)* plays important
roles in various physiological and pathological processes in-
cluding T cell activation, Ca
 
2
 
 
 
-induced apoptosis, endocy-
tosis of synaptic vesicles, muscle development, and skeletal
and cardiac muscle hypertrophy (Clipstone and Crabtree,
1992; Molkentin et al., 1998; Crabtree, 1999; Lai et al.,
1999; Wang et al., 1999; Rusnak and Mertz, 2000). Cn elic-
its these varied physiological functions by dephosphoryla-
tion of key phosphoproteins of the pathways (Crabtree,
1999; Li et al., 2000). A classic example of Cn-mediated
activation is dephosphorylation of transcription factor
NFATc, facilitating the nuclear localization of the active fac-
tor (O’Keefe et al., 1992; Beals et al., 1997).
Recently, we described a novel mitochondria to nucleus
stress signaling in C2C12 rhabdomyocytes and human pul-
monary A549 cells that involves altered Ca
 
2
 
 
 
 fluxes (Biswas et
al., 1999; Amuthan et al., 2002) and altered expression of sev-
eral nuclear gene targets (Amuthan et al., 2001). We showed
that depletion of mitochondrial DNA (mtDNA) or treatment
with mitochondrial-specific inhibitors, leading to the disrup-
tion of mitochondrial membrane potential (
 
  
 
m
 
), results in
elevated steady-state Ca
 
2
 
 
 
 ([Ca
 
2
 
 
 
]
 
c
 
). These changes were also
accompanied by a three- to fivefold increase in cytoplasmic
Cn, increased nuclear NFATc level, increased cytoplasmic
I
 
 
 
B
 
 
 
, and reduced RelA (p65) in the nucleus (Biswas et al.,
1999). In the present study, we show that nuclear p50 and
cRel are markedly increased in cells subjected to mitochon-
drial stress, suggesting the activation of an alternate pathway.
We demonstrate that an increase in Cn activity and attendant
inactivation of I
 
 
 
B
 
 
 
 are distinctive features of the mitochon-
drial stress–induced activation of NF
 
 
 
B/Rel proteins. These
results for the first time provide a critical link between mito-
chondrial stress, Ca
 
2
 
 
 
 signaling, and activation of NF
 
 
 
B/Rel
factors. Results also demonstrate the novel features of the mi-
tochondrial stress signaling that are distinctly different from
the known cytokines and TNF
 
 
 
-induced signaling.
 
Results
 
Activation of NF
 
 
 
B/Rel factors by mitochondrial stress 
and by overexpression of CnA in C2C12 cells
 
Recently, we generated a series of C2C12 cell lines contain-
ing varying levels of mtDNA by treatment with ethidium
bromide (Biswas et al., 1999). mtDNA-depleted cells and
also control cells treated with carbonyl cyanide-m chlo-
rophenylhydrazone (CCCP), a mitochondria-specific iono-
 
*Abbreviations used in this paper: 
 
  
 
m
 
,
 
 
 
mitochondrial membrane potential;
CCCP, carbonyl cyanide-m chlorophenylhydrazone; Cn, calcineurin;
DSP, dithiobis(succinimidylpropionate); LMB, leptomycin B; mtDNA,
mitochondrial DNA.
Figure 1. Cytoplasmic and nuclear levels of I B  and I B  in 
control, mtDNA-depleted, and reverted C2C12 cells. (A) Postnuclear 
or nuclear protein fractions (30  g protein each) from control, 
mtDNA-depleted, and reverted C2C12 cells were subjected to 
immunoblot analysis using the antibodies indicated in the figure. 
YY1 and Na
 /K
  ATPase were used as loading controls and also for 
assessing the levels of cross-contamination. Numbers in parentheses 
underneath stained bands represent relative band intensities. (B) 
Cells transfected with I B  or I B  cDNAs were stained with 
antibodies to respective proteins and secondary antibodies Alexa 594 
anti–mouse and Alexa 488 anti–rabbit for I B  and I B , respectively. 
One set of cells in each case was treated with LMB, 5 nM for 4 h, 
as indicated.T
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phore, showed disrupted 
 
  
 
m
 
 and elevated [Ca
 
2 ]c. These
changes were reversed to near control cell levels in reverted
cells, whose mtDNA content was brought back to  70% of
control cells by growing them in the absence of ethidium
bromide. In the present study, we investigated mechanisms
of mitochondrial stress–induced activation of NF B/Rel.
Immunoblot in Fig. 1 A shows that the cytoplasmic I B 
increased two- to threefold in mtDNA-depleted C2C12
cells, whereas I B  reduced markedly and returned to near
control cell levels in reverted cells. Additionally, the nuclear
cRel and p50 levels were increased markedly in mtDNA-
depleted cells and returned back to near control cell level in
reverted cells. In keeping with its chaperone-like function
(Tam and Sen, 2001), a significant amount of I B  was de-
tected in the nuclear extract from control cells that was re-
duced by 50–60% in the mtDNA-depleted cells (Fig. 1 A).
However, there was no detectable I B  in the nuclear frac-
tions of all three cell types. The levels of Na
 /K
  ATPase
and nuclear transcription factor YY1 used as loading con-
trols for postnuclear and nuclear fractions, respectively, did
not vary by mtDNA depletion and reversal. Finally, there
was no detectable YY1 in the postnuclear fraction and Na
 /K
 
ATPase in the nuclear fraction, indicating the purity of the
subcellular fractions used.
The lack of significant I B  in the nuclear compartment
was further investigated by immunofluorescence microscopy
of C2C12 cells treated with leptomycin B (LMB), an inhibi-
tor of CRM1-mediated export of protein from nucleus to cy-
toplasm. As shown in Fig. 1 B, in both control and LMB-
treated C2C12 cells there was no significant nuclear staining
with antibody to I B  (Fig. 1 B). I B  antibody yielded a
distinctly different staining pattern. An intense nuclear stain-
ing was observed in cells treated with LMB, and mostly cyto-
plasmic staining was observed in control cells. These results
support the conclusion that, unlike I B , I B  is not trans-
located to the nuclear compartment in C2C12 myocytes.
Immunoblot in Fig. 2 A shows a fivefold reduced cyto-
plasmic I B  and three- to sixfold increased nuclear p50
and cRel levels in CCCP-treated C2C12 cells and in
mtDNA-depleted cells. In addition, it shows that all of these
changes are sensitive to FK506, a Cn inhibitor (O’Keefe et
al., 1992) and also Ca
2  chelator EGTA/AM. Therefore, we
investigated the role of Cn in I B  inactivation and associ-
ated nuclear translocation of NF B/Rel factors by overex-
pressing CnA , the catalytic subunit of the enzyme in con-
trol C2C12 myocytes. FK506 treatment was used as a
control to ascertain the role of Cn in I B  inactivation. Im-
munoblot in Fig. 2 B shows that overexpression of wild-type
CnA  (CnA) caused a 40% reduction in cytoplasmic I B 
levels but no reduction of I B . Furthermore, addition of
10 nM FK506 resulted in increased I B  in the cytoplasm
of both control cells and cells transfected with CnA cDNA
Figure 2. Role of Ca
2  and Cn on dephosphorylation of I B  and steady-state 
levels of NF B/Rel proteins. (A) Control and CCCP-treated (25  M for 2 h) 
C2C12 cells were incubated with or without added FK506 (10 nM) or EGTA/AM 
(30  M). Alongside mtDNA-depleted C2C12 cells were also incubated for 2 h 
with or without inhibitors. Nuclear and postnuclear protein fractions (30  g 
each) were subjected to immunoblot analysis using indicated antibodies. 
(B) Postnuclear fractions (30  g each) of C2C12 cells transfected with CnA 
cDNA and treated with FK506 as in A were analyzed by immunoblot analysis 
using antibodies against I B  or I B . (C) Postnuclear fractions (0.5 mg protein) 
from control and transfected cells were immunoprecipitated with I B  antibody as 
described in Materials and methods. The immunoprecipitates were subjected 
to immunoblot analysis using Ser-phosphate antibody. (D) The in vivo effects of 
CnA on I B  phosphorylation. C2C12 cells transfected with WT and  PEST 
domain mutant I B  or CnA cDNAs were labeled with 
32P-orthophosphate and 
treated with or without FK506 (10 nM) as described in Materials and methods. The 
top panel shows the extent of 
32P labeling of I B  detected by autoradiography, 
and the middle and bottom panels show the immunoblot analyses for the levels 
of I B  and CnA, respectively. The numbers in parentheses in A–D underneath 
the gel bands show relative band intensities determined by imaging through 
Bio-Rad Laboratories Fluor-S Imager.T
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constructs. The reduced I B  in cells overexpressing CnA is
likely due to increased degradation, since we did not detect
any increase in the nuclear I B  (unpublished data). The
results also suggest that the basal Ca
2  ( 75 nM), prevalent
in control C2C12 cells (Biswas et al., 1999), is sufficient to
activate ectopically expressed CnA.
Fig. 2 C shows the steady-state phosphorylation status of
I B  in cells transfected with CnA in the presence or ab-
sence of FK506. In control cells, the level of phosphorylated
I B  increased about threefold after FK506 treatment. The
level was reduced by  20-fold in cells overexpressing CnA,
which was nearly completely reversed by FK506 treatment.
The role of Cn in the dephosphorylation of I B  under in
vivo conditions was investigated by metabolic labeling of en-
dogenous or ectopically expressed I B  with 
32P-orthophos-
phate. Fig. 2 D shows that phosphorylation of endogenous
I B  was markedly inhibited by overexpressing CnA, which
was effectively reversed by FK506 (lanes 1–3). Similarly,
phosphorylation of ectopically expressed flag-tagged I B 
was inhibited by cotransfection with CnA cDNA, which was
effectively reversed by FK506. The PEST domain deletion
mutant of I B  was phosphorylated at very low levels com-
pared with WT protein. The phosphorylation of mutant
protein was not affected by either overexpression of CnA or
treatment with FK506 and may represent nonspecific phos-
phorylation at sites outside the PEST domain. These results
Figure 3. Increased Cn and mitochondrial stress induce 
nuclear Rel protein levels. Control C2C12 cells were 
transfected with Cn cDNA or treated with CCCP (25  M 
for 2 h) in the presence or absence of added FK506 (10 nM). 
(A) Nuclear and postnuclear cell fractions (30  g protein 
each) were subjected to immunoblot analysis with indicated 
antibodies. Values in parentheses under each panel 
show relative band intensities. YY1 and Na
 /K
  ATPase 
antibodies were used to monitor protein loading and 
cross-contamination between the two subcellular fractions. 
(B–E) Gel mobility shift analysis with nuclear extracts from 
control or transfected C2C12 cells or mtDNA-depleted 
cells. In B, D, and E, NF B consensus probe was used, whereas in C ZBP-89 DNA was used as a probe. In B, supershift with indicated 
antibody (1–2  l antibody) was performed. Treatment with FK506 and CCCP were as in Fig. 2.
suggest that I B  is subject to Cn-mediated dephosphoryla-
tion of COOH-terminal PEST domain sites.
Immunoblot in Fig. 3 A shows that transfection with CnA
cDNA caused about a threefold increase in cytoplasmic CnA
level and about a twofold increase in nuclear p65, p50, cRel,
and NFATc levels. FK506 caused a 30–40% reduction in
nuclear p65 and a more pronounced reduction (70–80%) of
nuclear cRel, p50, and NFATc. Overexpression of I B  re-
sulted in a 70–80% reduction in nuclear cRel and p50 and a
25–30% reduction of RelA (p65) (unpublished data). YY1
and Na
 /K
  ATPase used as controls for nuclear and post-
nuclear proteins, respectively, were not detected significantly
in reciprocal cell fractions, suggesting their purity. These re-
sults suggest that Cn plays a role in modulating the activity
of NF B/Rel family factors.
The nuclear NF B/Rel levels under different conditions
were also estimated by gel mobility shift analysis using differ-
ent DNA probes. The gel pattern in Fig. 3 B shows that nu-
clear extract from mtDNA-depleted cells yielded a more in-
tense complex with NF B DNA probe than the control
nuclear extract. The DNA-bound complexes in both cases
were competed by a 20-fold excess unlabeled probe. Fig. 3 C
shows that under the same reaction condition the nuclear ex-
tracts from control, mtDNA-depleted, and CCCP-treated
C2C12 cells yielded complexes of comparable intensity with
DNA probe specific for a ubiquitously expressed transcriptionT
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factor, ZBP-89 (Feo et al., 1995). These results indicate that
variations in the extent of protein binding to NF B DNA in
Fig. 3 B is not due to variations in the input proteins. The gel
shift pattern in Fig. 3 D shows that transfection with CnA
cDNA yields an intense NF B-specific complex comparable
to that of nuclear extract from mtDNA-depleted cells (Fig. 3
B). As expected, the DNA-bound complex was supershifted
with antibodies to p65, p50, and cRel. Treatment of trans-
fected cells with FK506 caused a drastic reduction in complex
formation, confirming the role of Cn in increased DNA
binding in these cells. The gel pattern in Fig. 3 E shows that
nuclear extract from CCCP-treated cells also yielded a more
intense NF B complex compared with extract from control
C2C12 cells. These results are consistent with the results of
immunoblot analysis in Fig. 2 A and Fig. 3 A.
Physical interaction and dephosphorylation of I B  in 
vitro by calcineurin
Dephosphorylation of I B  by Cn was tested in vitro using
purified Cn and 
32P-labeled I B . Fig. 4 A shows that Cn
alone had a negligible effect when the reaction was per-
formed at 4 C for 10 min. Under these conditions, a combi-
nation of Cn and calmodulin had a marginal effect (Fig. 4
A, lane 4), which was enhanced by adding Ca
2  and Mn
2 
(Fig. 4 A, lane 5). However, parallel reactions run at 30 C
for 5 min yielded a 12–50-fold more pronounced dephos-
phorylation of I B  (Fig. 4 A, lanes 6 and 7), which was Cn
dependent (Fig. 4 A, lanes 7 and 8). Immunoblot analysis of
parallel reactions (Fig. 4, A and B, bottom panels) showed
comparable levels of I B , suggesting no protein degrada-
tion during in vitro incubation. Furthermore, dephosphory-
lation of I B  by Cn was inhibited by RII peptide in a dose-
dependent manner (Fig. 4 B). These results show for the
first time that Cn plays a direct role in the dephosphoryla-
tion of I B .
Phosphorylation of COOH-terminal PEST domain 
is critical for the in vivo interaction of I B  
with calcineurin
If active phosphorylated I B  binds to Cn under in vivo
conditions, one would expect Rel family proteins to also be
part of this complex. This possibility was tested by chemical
cross-linking of ectopically expressed human I B  using re-
versible cross-linker. The flag-tagged I B  formed two com-
plexes, one migrating with an apparent molecular mass of
250 kD and the second with  150 kD (Fig. 5, A–E). The
250-kD complex contained I B , cRel, p50, RelA, and
CnA (Fig. 5, A–E) as tested by immunoblot analysis. Al-
though not shown, this complex also contained CnB and
calmodulin. The faster migrating 150-kD complex, on the
other hand, contained I B  and all three Rel proteins (Fig.
5, A–C and E) but no detectable Cn (Fig. 5 D). These com-
plexes could be dissociated into individual protein subunits
by treatment with 1 mM DTT (unpublished data). Based
on their size, we infer that each complex contains one homo
or heterodimer of Rel proteins. Both the 250- and 150-kD
complexes also lacked significant I B  (Fig. 4 F). However,
analysis of an equivalent aliquot of cytoplasmic protein
showed the presence of I B  in the input protein. FK506
selectively inhibited the formation of the 250-kD complex
but had no effect on the formation of the 150-kD complex.
Transfection with PEST II domain deletion construct,
hI B / PEST, resulted in vastly reduced 250-kD complex,
whereas the level of the 150-kD complex was not affected.
Similarly, mutation at S313,315A (hI B /S313,315A)
caused a marked reduction in the 250-kD complex to a level
similar to that observed with the PEST domain–deleted pro-
tein, without altering the level of the 150-kD complex. On
the other hand, mutation at S315 (hI B /S315A) only
marginally reduced the level of the 250-kD complex. It
should be noted that the complexes with  PEST and
S313,315A mutant hI B  did not contain detectable Cn
(Fig. 5 D) even when the blot was overdeveloped (unpub-
lished data). These ectopically expressed mutant I B  pro-
teins, however, formed a minor 250-kD complex as detected
by antibodies to p50, cRel, and I B  (Fig. 5, A–C and E).
These latter complexes are probably due to interaction of
I B  with other isoforms of Cn. The results show that Rel
protein–bound I B  forms a ternary complex with Cn un-
Figure 4. Dephosphorylation of I B  by calcineurin. In vitro 
reactions were run using purified calcineurin and 
32P-labeled I B  
(A) as described in Materials and methods. Assays were performed 
in duplicate at 4 or 30 C with indicated additions. (B) Dose-
dependent inhibition of Cn-mediated dephosphorylation of 
32P I B  
by RII peptide (0 to 150 molar excess). For both A and B, one set 
of reaction was immunoprecipitated with I B  antibody, while a 
duplicate set was subjected to immunoblot analysis.T
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der in vivo conditions and that phosphorylation of PEST
domain, particularly at the S313/315 positions, are impor-
tant for the I B –NF B complex to bind to Cn. The PEST
domain mutations did not have adverse effects on I B 
binding to NF B/Rel proteins as seen by no change in the
level of the 150-kD complex. Results also show that FK506
inhibits the interaction of I B  with Cn in the formation
for the 250-kD complex but does not interfere with the in-
teraction of I B  with NF B/Rel proteins. We believe that
the 150-kD complex represents a static pool of the I B –
Rel complex that can be converted to the dynamic 250-kD
complex by PEST domain phosphorylation.
The difference in the binding affinities of I B  and I B 
with Cn was further ascertained by the antibody pull-down
assay (Fig. 5 G). Antibody to CnA pulled down I B  (Fig.
5 G, lane 1), but not I B , at a detectable level (Fig. 5 G,
lane 2). Similarly, I B  antibody failed to coimmunopre-
cipitate CnA (Fig. 5 G, lane 3), whereas I B  antibody
coimmunoprecipitated CnA (Fig. 5 G, lane 4). Lanes 5–7
show that the complex pulled down by CnA antibody also
contained p65, p50, and cRel, further confirming that Cn
physically interacts with the I B –NF B complex.
The role of COOH-terminal PEST domain in binding to
Cn was further tested by the antibody pull-down assay. Cy-
toplasmic protein from C2C12 cells transfected with various
hI B  cDNA constructs was immunoprecipitated with flag
antibody, and the immunoprecipitates were analyzed for
the level of Cn and I B . Immunoblot in Fig. 5 H shows
that flag antibody immunoprecipitated comparable levels of
I B  from cells expressing WT and mutant ( PEST, S313/
315A and S315A) constructs. The level of Cn coimmuno-
precipitated with different I B  proteins varied, however.
The WT I B  pulled down the highest level of CnA,
whereas its level was significantly reduced by 60% with the
S315A mutant I B . However, in the case of  PEST and
S313,315A mutant proteins, no significant CnA was pulled
down. Although not shown, immunoprecipitation of in
vitro translation products yielded a similar pattern of coim-
munoprecipitation. These results further support the possi-
bility that I B  binds to CnA through its COOH-terminal
PEST domain, and S313 and 315 residues are critical for
this binding.
Role of Cn and I B  in mitochondria to nucleus 
stress signaling
The physiological significance of I B ’s interaction with Cn
was investigated using the muscle tissue from CnA  knock-
out mouse (Zhang et al., 1996) based on the rationale that
reduced Cn should result in increased cytoplasmic I B 
and reduced nuclear NF B/Rel. RNase protection analysis
showed that the skeletal muscle from adult CnA 
 /  mice
contained significantly reduced CnA , and CnA  mRNAs
(unpublished data). Muscle extracts from CnA 
 /  mouse
used in this study had very low Cn activity. Immunoblot in
Fig. 6 A shows detectable CnA in skeletal muscle from wild-
type but not CnA 
 /  mice. As expected, the nuclear extract
from skeletal muscle of CnA 
 /  mouse showed no detect-
able NFATc. The level of I B  remains the same in muscle
tissue from wild-type and CnA 
 /  mice, whereas the level
of antibody reactive I B  increased by approximately two-
Figure 5. Ectopically expressed I B  forms a ternary complex with Cn 
and Rel family proteins. C2C12 cells were transfected with flag-tagged 
WT, S313,315A, or PEST domain–deleted hI B  cDNAs, and cytosolic 
protein factions (1 mg protein each) of transfected cells treated with or without FK506 (10 nM) were subjected to cross-linking with DSP as 
described in Materials and methods. The cross-linked products were immunoprecipitated with anti-flag antibody, and the immunoprecipitates 
were subjected to immunoblot analysis (A–F) with indicated antibodies. In F, an aliquot of the cross-linked product (50  g protein) was 
subjected to immunoblot analysis with antibody against I B  to ensure that the extract indeed contained the protein. (G) Physical interaction 
of I B  with Cn and Rel factors was tested by the antibody pull-down assay. Cytosolic fractions (1 mg protein each) from control C2C12 cells 
were immunoprecipitaed with Cn, I B , or I B , and the immunoprecipitates were probed with a combination of indicated antibodies. 
(H) Interaction of I B  with Cn through its PEST domain was tested by antibody pull-down assay. Postnuclear fraction from C2C12 cells 
transfected as in G was subjected to immunoprecipitation with flag antibody, and the immunoprecipitates were probed with antibodies to 
I B  and CnA . Numbers in parentheses in H indicate relative band intensities.T
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to threefold. Additionally, the nuclear p65 level was reduced
by  60%, whereas the p50 and cRel levels were reduced by
 70–80% in the CnA 
 /  mouse tissue. These results sup-
port the view that Cn plays an important role in the regula-
tion of the NF B pathway in vivo.
Previously, we showed that ryanodine receptor (RyR1)
Ca
2  channel and cathepsin L genes are up-regulated in
mtDNA-depleted C2C12 cells (Biswas et al., 1999; Amu-
than et al., 2001, 2002). In the present study, we assessed
the role of increased [Ca
2 ]c in induced expression of these
two potential target genes using EGTA/AM, a Ca
2  chela-
tor, and FK506, an inhibitor of Cn. RyR1 and cathepsin
L levels are increased  10-fold in both CCCP-treated and
mtDNA-depleted C2C12 cells compared with untreated
cells (Fig. 6 B). In support of the results in Fig. 6 A, FK506
effectively blocked the increase in both CCCP-treated and
mtDNA-depleted cells. EGTA/AM also effectively blocked
the increase of these proteins in both CCCP-treated and
mtDNA-depleted cells. These results further support the hy-
pothesis that mitochondrial stress operates through Ca
2 
and camodulin-mediated Cn activation.
The distinctive nature of mitochondrial stress signaling
and the involvement of I B  in the signaling cascade were
investigated using fibrosarcoma cell line HT1080I, which
carries a superrepressor mutant of I B  with vastly dimin-
ished phosphorylation and proteasome-mediated degradation
(Wang et al., 1996). The superrepressor protein binds to
NF B/Rel proteins with higher affinity, inhibiting their nu-
clear translocation and DNA binding (Wang et al., 1998).
The mutant cell line HT1080I is sensitive to TNF -medi-
ated apoptosis because the I B  pathway is refractory to
stress response. The HT1080V cells carrying wild-type I B 
exhibit normal response to TNF  (Wang et al., 1998).
Immunoblot in Fig. 7 A shows that, as reported before for
C2C12 cells, induction of mitochondrial stress by CCCP
treatment caused a reduction in postnuclear I B  in both
HT1080V and HT1080I cell lines. On the other hand,
treatment with TNF  did not alter the level of cytoplasmic
I B . The cytoplasmic I B  level was increased twofold by
CCCP treatment only in the wild-type cells but had no ef-
fect on the mutant HT1080I cells. Similarly, TNF  treat-
ment drastically reduced the cytoplasmic I B  level in wild-
type cells but had no effect on mutant cells. The effect on cy-
toplasmic I B  became apparent in less than 1 h of TNF 
treatment and remained unchanged up to 4 h of treatment
(unpublished data). The cytoplasmic CnA was induced in
both cell types by CCCP but not by TNF . CCCP treat-
ment caused a reduction in cytoplasmic cRel and p50 levels
with concomitant increase of these proteins in the nuclear
compartment in both cell lines. The nuclear cRel and p50
were increased in response to TNF  in wild-type cells but
did not increase in mutant cell line. Finally, the nuclear frac-
tion from both cell lines contained no detectable I B . The
levels of Na
 /K
  ATPase used as a loading control for post-
nuclear fraction, and YY1 for nuclear fraction, did not vary
under these conditions. These results show that both mutant
and wild-type cells respond similarly to CCCP-induced mi-
tochondrial stress, and Cn and NF B/Rel were activated in
both cases. Furthermore, results show that TNF  signaling
does not involve a change in Cn level and Cn-mediated inac-
tivation of I B .
Activation of NF B is regulated by several different ki-
nases, although IKK - and IKK -mediated phosphoryla-
tion is believed to be critical for the cytokine and TNF -
induced activation of NF B (Zandi et al., 1998; May et al.,
2000; Ghosh and Karin, 2002). We therefore tested the
roles of these kinases in mitochondrial stress–induced acti-
vation of NF B using IKK 
 /  and IKK 
 /  cell lines.
Fig. 7 B shows that CCCP-mediated mitochondrial stress
in these cells and also control fibroblasts caused reduced cy-
toplasmic Rel protein levels and also I B  but had no effect
Figure 6. Levels of mitochondrial stress–induced NF B pathway 
proteins in CnA 
 /  muscle and cells treated with Ca
2  chelators. 
(A) The nuclear and postnuclear fractions (25  g protein each) of 
skeletal muscle tissues from wild-type and CnA 
 /
  mice were 
analyzed by immunoblot analysis with the indicated antibodies. 
Other details are as in the legend to Fig. 1 and as described in 
Materials and methods. (B) Control and mtDNA-depleted C2C12 cells 
treated with or without EGTA/AM and FK506 were fractionated, and 
postnuclear fractions were subjected to immunoblot analysis with 
the indicated antibodies. Values in the parentheses in B indicate 
relative band intensities.T
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on the cytoplasmic I B . Similarly, nuclear cRel, p50, and
p65 in all three cell types were increased two- to fivefold in
response to mitochondrial stress. These results suggest that
mitochondrial stress–induced activation of NF B may oc-
cur through a pathway other than that involving IKK  and
IKK  kinases.
Distinctive nature of TNF  and 
mitochondrial stress–induced NF B targets
Previous studies from our laboratory showed that mitochon-
drial stress induced the expression of several marker genes
(Biswas et al., 1999; Amuthan et al., 2001, 2002). In the
present study, using RyR1 and cathepsin L genes as markers,
we investigated whether TNF -mediated and mitochon-
drial stress–induced signaling pathways affect the same or
different gene targets. Immunoblot in Fig. 8 A shows that
expression of both RyR1 Ca
2  channel and cathepsin L pro-
teins were induced by CCCP treatment in both HT1080V
and HT1080I cells, but the level of IP3 channel protein re-
mained the same (Fig. 8 A). TNF -mediated stress signaling
in both HT1080V and HT1080I cells failed to induce the
expression of RyR1 and cathepsin L proteins, further dem-
onstrating the distinctive nature of the two signaling path-
ways. Although not shown, the induction was at the tran-
scription level as indicated by increased mRNA levels.
Furthermore, overexpression of  PEST domain or S313A
mutants of I B  in cells treated with CCCP resulted in
complete reversal of both RyR1 and cathepsin L gene ex-
pression (Fig. 8 B). However, overexpression of S315A
I B  resulted in partial reversal (Fig. 8 B). These results
provide direct evidence that Cn-mediated inactivation of
I B  is critical for mitochondrial stress–induced activation
of marker genes.
The ability of PEST domain–mutated I B  in impeding
the propagation of mitochondrial stress signaling was further
tested in control C2C12 cells overexpressing CnA and also
mtDNA-depleted cells that contain elevated Cn activity as
follows. Initially, the effect on the marker gene expression
was tested. Immunoblot in Fig. 8 C shows that transfection
of control C2C12 cells with CnA yielded increased steady-
state levels of RyR1 and cathepsin L proteins as shown be-
fore. The level of IP3 channel protein was not increased
under these conditions. Cotransfection with S313,315A
mutant I B  drastically reversed the levels of antibody reac-
tive RyR1 and cathepsin L proteins in both control and
mtDNA-depleted cells. In the second series of experiments,
we tested the effect of overexpression of S313,315A mutant
I B  on the nuclear and cytoplasmic distribution of Rel
proteins. Immunoblot in Fig. 8 D shows that transfection of
control C2C12 cells with hI B WT cDNA resulted in vastly
reduced nuclear p65, p50, and cRel levels with simultaneous
increases of these factors and also that of I B  in the cyto-
plasm. Cotransfection with CnA cDNA caused a complete re-
versal with increased Rel proteins in the nucleus and reduced
levels in the cytoplasm. There was also a reduced cytoplas-
mic I B , suggesting that Cn-mediated dephosphorylation
may modulate its degradation. Transfection with hI B /
S313,315A cDNA had an effect similar to that with I B WT
construct. However, the inhibitory effect of this mutant was
not reversed by cotransfection with CnA. These results further
Figure 7. Distinctive features of mitochondrial stress–induced 
NF B activation. (A) Postnuclear fractions (30  g protein each) of 
HT1080V and HT1080I cells treated with or without CCCP or TNF  
as described in the legend to Fig. 6 were subjected to immunoblot 
analysis with indicated antibodies. Results show that both RyR1 and 
cathepsin L are induced only by treatment with CCCP, not TNF . 
(B) Control 3T3, IKK 
 / , and IKK 
 /  fibroblast cells were treated 
with or without CCCP (25  M) as in A, and nuclear and cytoplasmic 
protein fractions (30  g each) were subjected to immunoblot 
analysis with indicated antibodies. In both A and B, levels of YY1 
and Na
 /K
  ATPase were used as loading controls for nuclear and 
postnuclear fractions, respectively.T
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demonstrate that Cn-mediated dephosphorylation is critical
for the inactivation of I B  and attendant release of NF B/
Rel proteins and that the S313,315A mutant I B  has a
dominant-negative effect on mitochondrial stress signaling.
Discussion
In recent studies, we described a new mechanism of mito-
chondria to nucleus stress signaling, which is initiated by
mtDNA and/or membrane damage and disruption of   m.
These changes caused a sustained increase in [Ca
2 ]c and al-
tered expression of an array of nuclear genes (Biswas et al.,
1999; Amuthan et al., 2001, 2002). The altered gene expres-
sion was also associated with changes in cell morphology and
formation of invasive phenotypes in otherwise noninvasive
C2C12 rhabdomyosarcoma and A549 lung carcinoma cells
(Amuthan et al., 2001, 2002). The mitochondrial stress–
induced biochemical changes included increased nuclear
p50 and cRel and marginally reduced RelA (p65) factors. In
the present study, we investigated whether the mechanism
of mitochondrial stress–induced activation of NF B/Rel
factors is distinct from, or overlaps with, TNF -medi-
ated NF B/Rel activation. Our results show that mitochon-
drial stress–induced activation of NF B/Rel factors occurs
through inactivation of I B  by Cn-mediated dephosphor-
ylation and subsequent release of Rel proteins for nuclear
translocation. We also demonstrate that phosphorylation at
the COOH-terminal PEST region is critical for the mito-
chondrial stress–induced inactivation of I B  and attendant
activation of NF B/Rel factors. It is likely that the  B Ras
binding (Fenwick et al., 2000) represents a distinct step of
I B  regulation, possibly a downstream event regulating its
degradation.
Nuclear entry and exit of I B  and I B  are important
parts of signal-mediated activation of NF B/Rel. The nu-
clear I B  plays an important role in the exit of Rel factors
from the nucleus at the end of cytokine or other signaling
events. Furthermore, LMB-sensitive CRM1 serves as an es-
sential vehicle for the exit of nuclear I B  to the cytoplasm
(Turpin et al., 1999; Huang et al., 2000; Tam et al., 2000).
I B , on the other hand, lacks the CRM1 binding domain
(Turpin et al., 1999; Tam et al., 2000), which raises ques-
tions about its nuclear entry and exit. In support of recent
studies (Malek et al. 2001; Tam and Sen, 2001), we also
failed to detect I B  in the nuclear compartments of C2C12
Figure 8. Distinctive nuclear gene targets of mitochondrial stress 
signaling and involvement of I B . (A) Postnuclear fractions (30  g 
protein each) of HT1080V and HT1080I cells treated with or without 
CCCP or TNF  as described in the legend to Fig. 7 were subjected 
to immunoblot analysis with indicated antibodies. Results show that 
both RyR1 and cathepsin L are induced only by treatment with 
CCCP, not TNF . (B) Control HT1080V cells or cells subjected to 
mitochondrial stress by treatment with CCCP (25  M for 1 h) were 
transfected with wild-type or mutated I B  cDNA constructs as 
indicated. Postnuclear extracts were subjected to immunoblot 
analysis with indicated antibodies. (C) Immunoblot analysis of 
postnuclear fractions (30  g each) of control and mtDNA-depleted 
C2C12 cells transfected with CnWT and hI B /S313,315A constructs. 
The blots were developed with indicated antibodies. Numbers in 
parentheses indicates relative band intensities. (D) Nuclear and 
cytoplasmic fractions (30  g each) of control C2C12 cells transfected 
with the indicated cDNAs were subjected to immunoblot analysis 
with antibodies to various Rel proteins or I B .T
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and HT1080 cells (Fig. 1, A and B, and Fig. 7 A). Therefore,
I B  appears to be a strictly cytoplasmic protein, indicating
yet another distinctive feature different from I B .
We present multiple lines of evidence for the physical and
functional interaction of I B  with the catalytic subunit of
Cn. Both endogenous and ectopically expressed I B  form a
ternary complex of  250 kD with Cn and NF B/Rel pro-
teins, as tested by reversible cross-linking with dithiobis(suc-
cinimidylpropionate) (DSP). Direct proof of the functional
association between I B  and Cn comes from in vitro exper-
iments showing that 
32P-labeled I B  is dephopshorylated
by purified Cn in the presence of calmodulin and other nec-
essary cofactors. In vivo and in vitro association of I B  with
Cn and also its Cn-dependent dephosphorylation are inhib-
ited by FK506 and RII peptide, well-known inhibitors of cat-
alytic function of Cn (O’Keefe et al., 1992; Enz et al., 1994).
Notably, the effect of FK506 is targeted to complexes con-
taining Cn but not the 150-kD binary complexes of I B 
and NF B/Rel proteins. This is probably the first demon-
stration of a functional interaction between I B  and Cn.
Cn binds to diverse protein substrates including type II
cAMP-dependent protein kinase, protein phosphatase in-
hibitor-1, myosin light chains,  -subunit of phosphorylase
kinase, G substrate, DARPP-32, dynamin, tau factor,
NMDA receptor, NO synthase, and NFATc (for reviews see
Rusnak and Mertz, 2000; Shibasaki et al., 2002) through its
phosphatase active site leading to protein dephosphoryla-
tion. A sequence domain spanning residues 81–99 of type II
cAMP-dependent protein kinase, designated as RII domain,
is involved in interaction with the active site of Cn. The RII
peptide has been extensively used as a site-specific inhibitor
of Cn phosphatase. A common feature among the protein
substrates of Cn is the conservation of phosphoprotein se-
quence similar to the RII domain. The COOH-terminal
PEST domain from the mouse and human I B  (sequence
306–322) shows  80% structural homology ( -sheet struc-
ture) of RII peptide (Blumenthal et al., 1986) and contains
acidic phosphorylatin sites. Indeed, RII peptide inhibited
binding of I B  to Cn (Fig. 4 B). Results of chemical cross-
linking and antibody pull-down assay (Fig. 5, D and H)
show that I B , lacking the COOH-terminal PEST do-
main, or substituted S313 and S315 CKII target sites from
this domain, failed to interact with Cn. Although not
shown, even S to E substituted protein failed to bind to Cn,
suggesting that phosphorylated Ser residues at 313 and 315
positions are critical for binding. Therefore, binding of
I B  with Cn appears to vary from that of NFAT family
members in two ways. First, the 13-aa segment (Cn binding
peptide A) from the NH2-terminal domain of NFAT binds
to Cn even in the absence of phosphorylation (Aramburu et
al., 1998). Second, I B  binding to Cn does not appear to
involve a second COOH-terminal site similar to that shown
for some members of NFAT proteins (Park et al., 2000).
Furthermore, mutations targeted to PEST domain phos-
phorylation sites of I B  also acted as a persistent inhibitor
of Cn-mediated activation of NF B/Rel (Fig. 8).
Previous studies show that phosphorylation at the COOH-
terminal PEST domain sites (Thompson et al., 1995; Chu et
al., 1996; Schwarz et al., 1996; McKinsey et al., 1997; Tran
et al., 1997; Weil et al., 1997) are important for the func-
tion of I B . It was shown that dephosphorylation of puri-
fied I B  or discrete PEST domain mutations affected its
ability to bind NF B/Rel dimmers (Chu et al., 1996; Mc-
Kinsey et al., 1997). In extension of these studies, we dem-
onstrate that mutations targeted to Ser 313 and 315 of the
PEST domain abolished Cn binding but had minimal effect
for binding to NF B/Rel factors. Our results suggest that
Cn-mediated dephosphorylation is critical for the inactiva-
tion of I B  and release of NF B/Rel.
TNF , interleukin 1, and other receptor-mediated signal-
ing pathways induce the activation of NF B/Rel factors
mostly through signal-mediated phosphorylation and inacti-
vation of I B , without significantly affecting the steady-
state levels of I B . Using the HT1080I mutant cell line,
which does not respond to TNF  and interleukin-mediated
signaling (Wang et al., 1996), we demonstrate that mito-
chondrial stress–induced activation of NF B/Rel occurs
through a mechanism distinctly different from the TNF 
signaling. First, the activation of Cn and reduction in the
steady-state level of I B  in response to CCCP treatment
occur in both wild-type HT1080V cells and mutant
HT1080I cell lines. However, TNF -mediated reduction in
I B  occurs only in HT1080V cells (Fig. 8). Furthermore,
TNF  treatment in both cell lines has no effect on the level
of I B . Second, mitochondrial stress response genes RyR1
and cathepsin L are induced in both cell types in response to
CCCP, a specific inducer of mitochondrial stress but not by
TNF . Results presented in this study therefore suggest that
the mitochondrial stress signaling follows a pathway dis-
tinctly different from TNF  and interleukin 1 signaling. A
direct proof for the involvement I B  in the mitochondrial
stress–induced signaling comes from experiments show-
ing  that ectopic expression of PEST domain–deleted or
S313,315A–substituted I B  caused a dramatic reduc-
tion in the expression of RyR1 and cathepsin L genes in
CCCP-treated HT1080V cells and mtDNA-depleted C2C12
cells (Fig. 8). A similar dominant-negative effect of the
S313,315A mutant of I B  on the mitochondrial stress sig-
naling, reversal of invasive property, and also cell morphol-
ogy of mtDNA-depleted A549 and C2C12 cells was shown
(Amuthan et al., 2002; unpublished data).
Several protein kinases, including CKII, GSK3, PKC ,
PKC , IKK , and IKK  regulate the activity of NF B,
though the precise mechanisms in some cases is not clear
(Ghosh and Karin, 2002). For example, CKII and GSK3 are
thought to modulate the DNA-binding activity of the nu-
clear Rel proteins by subunit phosphorylation (Ghosh and
Karin, 2002), though CKII may also activate NF B by
phosphorylation of I B  and I B  at their COOH-termi-
nal PEST domain sites (Chu et al., 1996; McElhinny et al.,
1996). Some studies suggest that CKII may phosphorylate
free I B  and I  B , whereas IKKs may phosphorylate
Rel protein–bound inhibitory proteins (Pando and Verma,
2000). Using a combination of gene knock out and an active
site inhibitor of activator protein, NEMO, it was shown that
IKK  and IKK  play critical roles in the activation of
NF B in response to lymphotoxin  , interleukin, and
TNF -induced stress signaling (DiDonato et al., 1997; May
et al., 2000; Pando and Verma, 2000; Ghosh and Karin,
2002). In further support of the distinctive nature of the mi-T
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tochondrial stress–induced activation of NF B different
from TNF -induced activation described above, CCCP, a
potent inducer of mitochondrial stress, induced NF B acti-
vation in IKK 
 /  and IKK 
 /  cells. These results further
suggest the possibility that the mitochondrial stress–induced
activation occurs through a pathway other than that involv-
ing the IKK - and IKK -mediated phosphorylation of
I B . Alternatively, IKK - and IKK -mediated phos-
phorylation of COOH-terminal sites of I B  may be a
downstream event that follows the Cn-dependent dephos-
phorylation of PEST domain sites.
In summary, our results provide evidence for the distinctive
nature of the mitochondria to nucleus stress signaling differ-
ent from various cytokines and receptor-mediated stress. Re-
sults also provide mechanistic insights into a novel-signaling
pathway by which NF B/Rel factors respond to Ca
2 - and
calmodulin-dependent process as summarized in Fig. 9. Our
working model proposes that activated Cn binds to the cyto-
plasmic I B –Rel complex and catalyzes the dephosphoryla-
tion of I B  at its COOH-terminal PEST domain. The Cn-
mediated dephosphorylation in turn causes inactivation of
I B , resulting in the release of active p50/cRel heterodimers
for translocation into the nuclear compartment.
Materials and methods
Cell culture and transfection
Control C2C12 murine myoblast cells and the mtDNA-depleted and re-
verted cells were generated and maintained as described previously (Bis-
was et al., 1999). HT1080 cells were grown in DME containing 10% FBS
and 1  penicillin and streptomycin. Cells were transfected with 5  g of
expression cDNA constructs/100-mm plate using the Fugene 6 (Roche
Biochemicals) transfection agent, which routinely yielded  70% transfec-
tion efficiency.
Subcellular fractionation and immunoblot analysis
Cultured cells and skeletal muscle tissue were homogenized in homogeni-
zation buffer (0.3 M sucrose, 10 mM Tris-HCl, pH 8.0, 10 mM NaCl, 3
mM MgCl2, 0.2 mM EDTA) containing phosphatase inhibitors (1 mM
NaVO4, 100  M molybdic acid, 10 mM NaF) and protease inhibitors (1
mM phenylmethylsulfonyl fluoride, 50  g/ml each leupeptin, pepstatin,
aprotinin, chymostatin, and antipain). Subcellular fractions were isolated
by differential centrifugation as described previously (Biswas et al., 1999).
Proteins were resolved by electrophoresis on 10 or 12% SDS–polyacryl-
amide gels (Laemmli, 1970) and subjected to immunoblot analysis as de-
scribed by Towbin et al. (1979). Blots were developed using Super Signal
West Femto maximum sensitivity substrate from Pierce Chemical Co.
Gel mobility shift assays
DNA–protein binding was assayed by gel mobility shift as described be-
fore (Amuthan et al., 2001). Binding was performed with 
32P end–labeled
NF B consensus DNA (5 -AGTTGAGGGGACTTTCCAGGC-3 ) of ZBP-89
DNA (5 -GGGTGGGGGGG-3 ). Binding reactions (20  l) contained
 0.1–0.2 ng of labeled DNA (10,000–15,000 cpm), 15  g of nuclear ex-
tract, and 2  g of poly (dI-dC) under conditions described previously
(Amuthan et al., 2001). DNA–protein complexes were resolved on 4%
nondenaturing polyacrylamide gels in 0.5%   Tris-Glycine (25 mM Tris,
100 mM glycine, 1 mM EDTA, pH 8.3). Competition with 20 molar excess
unlabeled DNA and antibody supershift were performed as described
(Amuthan et al., 2001).
Immunoprecipitation
Immunoprecipitation was performed by the protein A–Sepharose pull-down
method as described previously (Anandatheerthavarada et al., 1999) using 1 mg
equivalent of cytosolic proteins from control or transfected cells. The immuno-
precipitates were extracted with 2  Laemmli buffer devoid of  -mercaptoetha-
nol at 95 C for 5 min. Immunoprecipitation of in vitro–translated proteins was
performed essentially as described previously (Bhat and Avadhani, 1985).
Chemical cross-linking of NF B with Cn
Cross-linking was performed in vitro using 1 mg of cytosolic proteins diluted
to 500  l volume with 50 mM Hepes (pH 7.5). The cross-linking reaction
was performed with 500  M reversible cross-linker, DSP (Pierce Chemical
Co.) at 25 C for 30 min. Reaction was stopped by adding 100 mM Tris buffer
(pH 7.2). Cross-linked products were subjected to immunoprecipitation us-
ing monoclonal flag antibody and subjected to immunoblot analysis using
different antibodies to Rel factors, I B , I B , and calcineurin.
Protein phosphatase assay
I B  synthesized in vitro with unlabeled amino acids was phosphorylated
by adding [ -
32P]ATP and 10 U CKII (New England Biolabs Inc.). Phos-
phatase assays were performed in 50  l vol using 
32P-labeled proteins
(80,000 cpm) as the substrate in 50 mM Hepes (pH 7.5) containing 1 mM
CaCl2, 1 mM MnCl2, 3  M calmodulin (CaM), and 1.5  g of purified bo-
vine brain Cn (Calbiochem). The reactions were run at 4 or 30 C for 5 min
and subjected to immunoprecipitation as described above using I B  anti-
body. Immunoprecipitates were subjected to SDS–polyacrylamide gel, and
the gels were imaged using GS525 Molecular Imager (Bio-Rad Laborato-
ries). A parallel set was subjected to immunoblot analysis using I B  anti-
body for protein level.
Metabolic labeling of I B  in intact cells
Control C2C12 cells were transfected with CnAWT, flag-tagged I B WT,
or S313,315A cDNAs, and at 60 h posttransfection, cells were labeled for
4 h with 
32Pi (1 mCi/ml) in phosphate-depleted DME with or without
added FK506 (10 nM) as described by Chu et al. (1996). Cytosolic proteins
(0.5 mg each, 100,000 g supernatant fraction) were immunoprecipitated
with either I B  or flag antibody. Immunoprecipitates were resolved by
12% SDS-PAGE, and the labeled I B  was visualized by autoradiography.
Companion gels were subjected to immunoblot analysis using I B  and
Cn antibodies.
Figure 9. Model depicting mitochondrial 
stress–induced activation of Rel/NF B 
factors through Cn-mediated 
dephosphorylation of I B .T
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Immunocytochemistry
C2C12 cells were grown on coverslips were transfected with I B  or I B 
cDNAs (5  g) for 60 h. In some cases LMB (5 nM) was added during the
last 4 h of culturing. Fixing and staining of cells with primary and second-
ary antibodies were performed as described previously (Biswas et al.,
1999). Confocal microscopy was performed with a TCS laser confocal mi-
croscope (Leica).
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